Bausch Health Aktie
WKN DE: A2JQ1X / ISIN: CA0717341071
|
18.02.2026 22:33:29
|
Bausch Health Companies Posts Q4 Loss
(RTTNews) - Bausch Health Companies Inc. (BHC, BHC.TO) on Wednesday reported a net loss of $112 million for the fourth quarter, compared with a consolidated net income of $93 million for the fourth quarter of 2024.
On a per-share basis, the company reported a loss of $0.30 for the fourth quarter, compared with earnings of $0.25 for the fourth quarter of 2024.
Adjusted net income was $411 million for the fourth quarter, compared with $430 million for the fourth quarter last year.
Revenues were $2.80 billion for the fourth quarter, compared with $2.56 billion in the fourth quarter of 2024, an increase of 9%.
Excluding the impact of foreign exchange of $59 million, acquisitions of $1 million, and divestitures and discontinuations of $17 million, revenue increased by 6% on an organic basis compared with the fourth quarter of 2024.
Looking forward to the full year 2026, the company expects revenues of $10.625-$10.875 billion.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Bausch Health
|
28.04.26 |
Ausblick: Bausch Health vermeldet Zahlen zum jüngsten Quartal (finanzen.net) | |
|
14.04.26 |
Erste Schätzungen: Bausch Health legt Zahlen zum jüngsten Quartal vor (finanzen.net) | |
|
17.02.26 |
Ausblick: Bausch Health stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net) | |
|
03.02.26 |
Erste Schätzungen: Bausch Health öffnet die Bücher zum abgelaufenen Quartal (finanzen.net) |
Analysen zu Bausch Health
Aktien in diesem Artikel
| Bausch Health | 4,50 | -3,06% |
|